Pyogenic liver abscess and Toxic encephalopathy

Summary:

Toxic encephalopathy is found among people with Pyogenic liver abscess, especially for people who are male, 60+ old.

The study analyzes which people have Toxic encephalopathy with Pyogenic liver abscess. It is created by eHealthMe based on reports of 39 people who have Pyogenic liver abscess from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pyogenic liver abscess?

Pyogenic liver abscess (liver abscess caused by bacteria) is found to be associated with 399 drugs and 969 conditions by eHealthMe. Check the latest studies of Pyogenic liver abscess.

What is Toxic encephalopathy?

Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances) is found to be associated with 424 drugs and 617 conditions by eHealthMe. Check the latest studies of Toxic encephalopathy.



On Aug, 08, 2026

39 people who have Pyogenic Liver Abscess and Toxic Encephalopathy are studied.

Would you have Toxic encephalopathy when you have Pyogenic liver abscess?

Gender of people who have Pyogenic Liver Abscess and experienced Toxic Encephalopathy *:

  • female: 47.06 %
  • male: 52.94 %

Age of people who have Pyogenic Liver Abscess and experienced Toxic Encephalopathy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 5.88 %
  • 40-49: 2.94 %
  • 50-59: 2.94 %
  • 60+: 88.24 %

Common co-existing conditions for these people *:

  1. Bacteraemia (presence of bacteria in the blood): 2 people, 5.13%
  2. Hepatitis B: 2 people, 5.13%
  3. Streptococcal Infection: 1 person, 2.56%
  4. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 1 person, 2.56%
  5. Bacterial Infection: 1 person, 2.56%
  6. Brain Abscess: 1 person, 2.56%
  7. Cholangitis (infection of the bile duct): 1 person, 2.56%
  8. Cholecystitis Infective (infection of gallbladder capable to infect other organs): 1 person, 2.56%
  9. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 2.56%
  10. Fusobacterium Infection (bacterial infection): 1 person, 2.56%

Common drugs taken by these people *:

  1. Metronidazole: 19 people, 48.72%
  2. Meropenem: 4 people, 10.26%
  3. Levofloxacin: 3 people, 7.69%
  4. Piperacillin And Tazobactam: 2 people, 5.13%
  5. Mycophenolate Mofetil: 2 people, 5.13%
  6. Ceftriaxone: 2 people, 5.13%
  7. Tacrolimus: 2 people, 5.13%
  8. Vancomycin: 1 person, 2.56%
  9. Dapagliflozin: 1 person, 2.56%
  10. Aspirin: 1 person, 2.56%

Common symptoms for these people *:

  1. Movement - Uncoordinated: 5 people, 12.82%
  2. Speech Impairment (Adult) (inability to speak (adult)): 4 people, 10.26%
  3. Cerebellar Syndrome (impaired blood circulation to cerebellum due to lesion in artery): 4 people, 10.26%
  4. Eye Movements - Uncontrollable: 3 people, 7.69%
  5. Swallowing Difficulty: 3 people, 7.69%
  6. Nausea And Vomiting: 3 people, 7.69%
  7. Nervous System Disorder (a general class of medical conditions affecting the nervous system): 3 people, 7.69%
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 5.13%
  9. Gait Disturbance: 2 people, 5.13%
  10. Depressed Level Of Consciousness: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Toxic encephalopathy?

- Check whether Toxic encephalopathy is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Toxic encephalopathy:

All the conditions that are associated with Toxic encephalopathy:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Toxic encephalopathy and Pyogenic liver abscess, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: